EverSource Wealth Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.46K Buy
218
+36
+20% +$852 ﹤0.01% 3229
2025
Q4
$4.79K Hold
182
﹤0.01% 3143
2025
Q3
$3.11K Buy
182
+1
+0.6% +$14 ﹤0.01% 3352
2025
Q2
$2.27K Buy
181
+168
+1,292% +$2K ﹤0.01% 3469
2025
Q1
$155 Buy
13
+3
+30% +$41 ﹤0.01% 3746
2024
Q4
$146 Buy
+10
New +$140 ﹤0.01% 3488

Other funds holding ZYME

EverSource Wealth Advisors's ZYME Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Zymeworks (ZYME) stake by 20% in Q1 2026, buying an estimated $852 and bringing the position to 218 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3229.

EverSource Wealth Advisors first reported a position in ZYME in Q4 2024 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • EverSource Wealth Advisors held 218 shares of Zymeworks worth $5.46K as of Q1 2026.
  • EverSource Wealth Advisors bought 36 Zymeworks shares in Q1 2026, an estimated $852.
  • Zymeworks made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3229 holding.
  • EverSource Wealth Advisors first reported a position in Zymeworks in Q4 2024 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.